These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36671459)

  • 1. Lack of Epileptogenic Effects of the Creatine Precursor Guanidinoacetic Acid on Neuronal Cultures In Vitro.
    Poggio F; Brofiga M; Tedesco M; Massobrio P; Adriano E; Balestrino M
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency.
    Adriano E; Salis A; Damonte G; Millo E; Balestrino M
    Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency.
    Rossi L; Nardecchia F; Pierigè F; Ventura R; Carducci C; Leuzzi V; Magnani M; Cabib S; Pascucci T
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn errors of creatine metabolism and epilepsy.
    Leuzzi V; Mastrangelo M; Battini R; Cioni G
    Epilepsia; 2013 Feb; 54(2):217-27. PubMed ID: 23157605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidinoacetate N-methyltransferase deficiency: Case report and brief review of the literature.
    Libell JL; Lakhani DA; Balar AB; Khan M; Carpenter JS; Joseph JT
    Radiol Case Rep; 2023 Dec; 18(12):4331-4337. PubMed ID: 37808418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation.
    Schulze A; Ebinger F; Rating D; Mayatepek E
    Mol Genet Metab; 2001 Dec; 74(4):413-9. PubMed ID: 11749046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine deficiency syndromes.
    Schulze A
    Mol Cell Biochem; 2003 Feb; 244(1-2):143-50. PubMed ID: 12701824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT gene.
    Mercimek-Mahmutoglu S; Pop A; Kanhai W; Fernandez Ojeda M; Holwerda U; Smith D; Loeber JG; Schielen PC; Salomons GS
    Gene; 2016 Jan; 575(1):127-31. PubMed ID: 26319512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.
    Viau KS; Ernst SL; Pasquali M; Botto LD; Hedlund G; Longo N
    Mol Genet Metab; 2013 Nov; 110(3):255-62. PubMed ID: 24071436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism.
    Schulze A; Hess T; Wevers R; Mayatepek E; Bachert P; Marescau B; Knopp MV; De Deyn PP; Bremer HJ; Rating D
    J Pediatr; 1997 Oct; 131(4):626-31. PubMed ID: 9386672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development.
    Hanna-El-Daher L; Béard E; Henry H; Tenenbaum L; Braissant O
    Neurobiol Dis; 2015 Jul; 79():14-27. PubMed ID: 25896543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency.
    Hart K; Rohrwasser A; Wallis H; Golsan H; Shao J; Anderson T; Wang X; Szabo-Fresnais N; Morrissey M; Kay DM; Wojcik M; Galvin-Parton PA; Longo N; Caggana M; Pasquali M
    Mol Genet Metab; 2021; 134(1-2):60-64. PubMed ID: 34389248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine.
    Bianchi M; Rossi L; Pierigè F; De Angeli P; Aliano MP; Carducci C; Di Carlo E; Pascucci T; Nardecchia F; Leuzzi V; Magnani M
    Mol Ther Methods Clin Dev; 2022 Jun; 25():26-40. PubMed ID: 35317049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.
    Pasquali M; Schwarz E; Jensen M; Yuzyuk T; DeBiase I; Randall H; Longo N
    J Inherit Metab Dis; 2014 Mar; 37(2):231-6. PubMed ID: 24276113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.
    Braissant O; Henry H
    J Inherit Metab Dis; 2008 Apr; 31(2):230-9. PubMed ID: 18392746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency.
    Wojcik M; Morrissey M; Borden K; Teta B; Sicko R; Showers A; Sunny S; Caggana M
    Mol Genet Metab; 2022 Mar; 135(3):186-192. PubMed ID: 35120844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF.
    Jomura R; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
    Fluids Barriers CNS; 2022 Jun; 19(1):42. PubMed ID: 35658878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Human guanidinoacetate n-methyl transferase (GAMT) deficiency: A treatable inborn error of metabolism.
    Iqbal F
    Pak J Pharm Sci; 2015 Nov; 28(6):2207-11. PubMed ID: 26639513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanidinoacetate methyltransferase (GAMT) deficiency diagnosed by proton NMR spectroscopy of body fluids.
    Engelke UF; Tassini M; Hayek J; de Vries M; Bilos A; Vivi A; Valensin G; Buoni S; Zannolli R; Brussel W; Kremer B; Salomons GS; Veendrick-Meekes MJ; Kluijtmans LA; Morava E; Wevers RA
    NMR Biomed; 2009 Jun; 22(5):538-44. PubMed ID: 19288536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.